Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Sarcoma 1Head & Neck 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Breast Neoplasms 69Neoplasms 32Prostatic Neoplasms 30Lung Neoplasms 24Head and Neck Neoplasms 20Neoplasm Metastasis 15Motor Activity 14Colorectal Neoplasms 14Multiple Myeloma 13Ovarian Neoplasms 11Gastrointestinal Neoplasms 11Fatigue 10Carcinoma, Non-Small-Cell Lung 10cyclopia sequence 8Uterine Cervical Neoplasms 8Pancreatic Neoplasms 8Pain 8Lymphoma 8Anxiety Disorders 8Smoking Cessation 7Recurrence 7Neoplasms, Plasma Cell 7Esophageal Neoplasms 7Endometrial Neoplasms 7Carcinoma, Renal Cell 7Tobacco Use Cessation 6Rectal Neoplasms 6Oropharyngeal Neoplasms 6Leukemia 6Depression 6

Interventions

Carboplatin 12Paclitaxel 11Gemcitabine 11Capecitabine 7Irinotecan 6Fluorouracil 5Cisplatin 5Radiotherapy 4Oxaliplatin 4Leucovorin 4Bevacizumab 4pembrolizumab 3Filgrastim 3Etoposide 3Erlotinib Hydrochloride 3Cyclophosphamide 3etoposide phosphate 2atezolizumab 2Trastuzumab 2Topotecan 2Taxes 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Genetic Testing 2FAPI-46 2Docetaxel 2CP protocol 2Amifostine 2Albumin-Bound Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms, Unknown Primary × Surveys and Questionnaires × Clear all
NCT01624220 2026-05-12

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

M.D. Anderson Cancer Center

Phase NA Completed
41 enrolled 8 charts
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Prostatic Neoplasms, Sarcoma, Spinal Cord Neoplasms, Thyroid Neoplasms

NCT00353145 2012-08-02

Gemox as First and Second Line Therapy in Unknown Primary Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
29 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡